ABCB1 rs10248420: Understanding Your Genetic Variant
The rs10248420 variant is a single nucleotide polymorphism located within the ABCB1 gene, which encodes the P-glycoprotein efflux pump. This protein plays a critical role in regulating the transport of various substances, including certain medications, across the blood-brain barrier.
What each genotype means
Potential reduced antidepressant remission
Research suggests that individuals with this genotype may have a decreased likelihood of achieving remission when treated with certain antidepressants, such as amitriptyline, citalopram, paroxetine, or venlafaxine, compared to those with the GG genotype. This association is based on limited evidence, and clinical response is influenced by many other genetic and environmental factors. Please discuss your medication response and any concerns about your treatment plan with your clinician or pharmacist.
This genotype is common in many populations, though exact frequencies vary by ancestry.
Intermediate antidepressant response profile
Individuals with this genotype may show an intermediate likelihood of remission when treated with specific antidepressants like amitriptyline, citalopram, paroxetine, or venlafaxine, falling between the outcomes observed for the AA and GG genotypes. Because the evidence for this association is limited and clinical outcomes are complex, this information should not be used to guide treatment decisions on its own. Please consult your healthcare provider or pharmacist to discuss your specific treatment goals and medication efficacy.
This heterozygous genotype is frequently observed across diverse global populations.
Potential increased antidepressant remission
Some studies indicate that individuals with this genotype may have a higher likelihood of achieving remission when treated with certain antidepressants, including amitriptyline, citalopram, paroxetine, or venlafaxine, compared to those with the AA genotype. This finding is based on limited evidence, and many factors beyond this single genetic variant contribute to how well a medication works for an individual. Always discuss your treatment progress and any medication adjustments with your clinician or pharmacist.
This genotype is common, with the G allele occurring at a global minor allele frequency of approximately 0.35.
What is rs10248420?
A single nucleotide polymorphism (SNP) is a variation at a single position in a DNA sequence among individuals. The variant rs10248420 is located within the ABCB1 gene, also known as the multidrug resistance 1 (MDR1) gene. This gene provides instructions for making a protein called P-glycoprotein. In the context of human genetics, rs10248420 represents a specific site where the DNA sequence can differ between people. Researchers study these variations to understand if they contribute to differences in how individuals process medications or respond to various environmental factors. Because this variant is located in a gene responsible for drug transport, it has been a subject of interest in pharmacogenomics, the study of how genes affect a person's response to drugs.
The Role of the ABCB1 Gene
The ABCB1 gene encodes P-glycoprotein, a transmembrane protein that acts as an efflux pump. This pump is found in many tissues throughout the body, including the lining of the blood-brain barrier. Its primary function is to transport molecules, including toxins and certain therapeutic drugs, out of cells and back into the bloodstream. By doing so, P-glycoprotein limits the amount of these substances that can enter the brain. When the function or expression of this pump is altered, it may theoretically change the concentration of drugs that reach the central nervous system. Understanding the activity of this transporter is essential for researchers investigating why some individuals might experience different therapeutic effects or side effects when taking medications that are substrates for this pump.
Research and Clinical Evidence
Scientific research into the clinical impact of ABCB1 variants on antidepressant efficacy has yielded mixed results. While the biological mechanism—where P-glycoprotein regulates drug concentrations in the brain—is well-established in laboratory models, the direct link between specific SNPs like rs10248420 and patient outcomes remains debated. Meta-analyses and systematic reviews have often found that while some variants in the ABCB1 gene are associated with differences in drug transport, the evidence for a consistent, clinically significant impact on antidepressant treatment response or remission is limited. Because of these conflicting findings, this variant is not currently used as a standard clinical tool for predicting how a patient will respond to a specific medication. The complexity of drug response, which involves many genes and environmental factors, makes it difficult to isolate the effect of a single variant.
What You Can Do With This Information
It is important to understand that genetic information regarding variants like rs10248420 is for educational purposes and should not be used to make medical decisions. You cannot use this information to diagnose a condition or to determine the effectiveness of a medication. If you are curious about how your genetics might influence your health or your response to a prescribed treatment, the best course of action is to consult with your healthcare provider or a pharmacist. They are equipped to interpret your overall health profile, medical history, and current medications. Never change your medication dosage or stop taking a prescribed drug based on genetic test results without first speaking to your clinician, as they can provide guidance tailored to your specific clinical needs.
How common is this variant?
The global minor allele frequency (GMAF) for this variant is approximately 0.3476, indicating that it is relatively common across diverse human populations.
Frequently asked questions
Can I use this genetic test to choose my antidepressant?
No, current evidence does not support using this specific variant to guide the selection or dosing of antidepressants. Clinical decisions should always be based on a comprehensive evaluation by your doctor.
What does the ABCB1 gene do?
The ABCB1 gene produces P-glycoprotein, a pump that helps move substances, including some drugs, out of cells. It is particularly important at the blood-brain barrier where it limits the entry of certain compounds into the brain.
Is this variant associated with any diseases?
While researchers have studied this variant in the context of drug response and major depressive disorder, it is not considered a diagnostic marker for any specific disease. The associations found in studies are statistical and do not imply a direct cause-and-effect relationship.
Should I be worried if I have the A allele?
No, having a particular allele at this position is a normal part of human genetic variation. It does not indicate a health problem or a guaranteed response to any medication.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10248420?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ABCB1
This variant is studied for its influence on the pharmacokinetics of immunosuppressive drugs like cyclosporine and tacrolimus in transplant patients.
Synonymous variant (c.3435C>T) in ABCB1 linked to altered P-glycoprotein expression and multi-drug transporter pharmacokinetics.
Nonsynonymous variant in ABCB1 altering P-glycoprotein transporter kinetics.
This SNP is linked to variations in the pharmacokinetics of drugs that are substrates for the ABCB1 transporter protein.
A variant associated with potential differences in drug absorption and clinical outcomes in patients undergoing specific pharmacological therapies.
Synonymous exon 26 variant in ABCB1 linked to altered mRNA stability and variable response to multiple cardiovascular medications.